Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High Throughput Immunoassays Authorized for Emergency Use
Detection Principle
ImmunoAssay-Antibody
Target
IgG
Testing Method Category
Other Immuno assay
Testing Method
Abbott Architect immunoassay, DiaSorin Liaison, Ortho Vitros, Euroimmun
Testing Method - Additional Info
comparison of results obtained using 4 high-throughput SARS-CoV-2 IgG EUA immunoassays (chemiluminescent immunoassays, chemiluminescent microparticles immunoassays and enzyme-linked immunosorbent assay)
Reported Performance
PPA: 99.7% (Abbott), 94.3% (Diasorin), 100% (Ortho), 99.8% (Euroimmun) ; NPA: 97.7% (Abbott), 97.5% (Diasorin), 100% (Ortho), 96.7% (Euroimmun)
Sample Size
1200 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements